CSBR : Summary for Champions Oncology, Inc. - Yahoo Finance

U.S. Markets closed

Champions Oncology, Inc. (CSBR)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.15-0.01 (-0.32%)
At close: 4:00PM EDT
People also watch
CGNTEYEGZSANCLRBCRTN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.16
Open3.17
Bid2.00 x 200
Ask4.02 x 100
Day's Range3.05 - 3.25
52 Week Range1.11 - 4.79
Volume11,755
Avg. Volume119,352
Market Cap34.58M
Beta-0.52
PE Ratio (TTM)-4.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
    Capital Cube4 days ago

    Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017

    Categories: Yahoo Finance Get free summary analysis Champions Oncology, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Champions Oncology, Inc. – Aviragen Therapeutics Inc, Charles River Laboratories International, Inc., Exelixis, Inc., Heska Corporation, NanoString Technologies, Inc., Celldex Therapeutics, Inc. and Foundation Medicine, Inc. (AVIR-US, CRL-US, ... Read more (Read more...)

  • PR Newswire10 days ago

    Champions Oncology Reports 40% Revenue Growth

    HACKENSACK, N.J., March 16, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use ...

  • PR Newswire10 days ago

    Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland

    HACKENSACK, N.J., March 16, 2017 /PRNewswire/ -- Champions Oncology, Inc. (CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced plans for opening a new lab facility in Rockville, Maryland during the second quarter of its 2018 fiscal year. Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs.